» Articles » PMID: 32998310

Altered Ovarian Inositol Ratios May Account for Pathological Steroidogenesis in PCOS

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2020 Oct 1
PMID 32998310
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

The presence of abnormal ovarian ratios of myo-inositol (MI) to D-chiro-inositol (DCI) is a recurrent feature in PCOS. Available evidence suggests that MI and DCI may modulate steroid biosynthesis, likely in an opposite manner. Specifically, MI seems to induce estrogen production, while DCI has a role in the synthesis of androgens. Elevated insulin levels, generally associated with PCOS, alter the physiological MI/DCI ratio, increasing MI-to-DCI conversion through activation of a specific epimerase enzyme. DCI directly increases testosterone biosynthesis in thecal cells and reduces its conversion to estradiol by downregulating aromatase enzyme in granulosa cells. This manuscript reviews the literature that supports the connection between altered MI/DCI ratios and pathological steroidogenesis observed in PCOS women. Furthermore, it discusses the application of inositol-based treatment protocols in managing PCOS symptoms and improving the quality of patients' life.

Citing Articles

A retrospective study "myo-inositol is a cost-saving strategy for controlled ovarian stimulation in non-polycystic ovary syndrome art patients.".

Aragona C, Russo M, Myers S, Espinola M, Bilotta G, Unfer V Health Econ Rev. 2025; 15(1):20.

PMID: 40088331 DOI: 10.1186/s13561-025-00609-8.


Myo-Inositol and Its Derivatives: Their Roles in the Challenges of Infertility.

Placidi M, Casoli G, Tatone C, Emidio G, Bevilacqua A Biology (Basel). 2024; 13(11).

PMID: 39596891 PMC: 11592302. DOI: 10.3390/biology13110936.


The latest reports and treatment methods on polycystic ovary syndrome.

Stanczak N, Grywalska E, Dudzinska E Ann Med. 2024; 56(1):2357737.

PMID: 38965663 PMC: 11229724. DOI: 10.1080/07853890.2024.2357737.


Treatment With a Patented 3.6:1 Myo-Inositol to D-chiro-Inositol Ratio, Antioxidants, Vitamins and Minerals Food Supplement in Women With a History of Assisted Reproductive Technique (ART) Failures: A Series of Case Reports.

Armijo-Sanchez A, Benitez Castillo N, Garcia-Vidal E, Luna Chadid M, Salvador Ballada C, Valls Ricart G Clin Med Insights Case Rep. 2024; 17:11795476241242265.

PMID: 38559382 PMC: 10981332. DOI: 10.1177/11795476241242265.


Protective effects of vanillic acid on letrozole-induced polycystic ovarian syndrome: A comprehensive study in female wistar rats.

V Gadhave P, V Sutar G, Sajane S, Redasani V, Das K, Prasad P D Saudi Pharm J. 2024; 32(2):101953.

PMID: 38288132 PMC: 10823135. DOI: 10.1016/j.jsps.2024.101953.


References
1.
Bevilacqua A, Bizzarri M . Inositols in Insulin Signaling and Glucose Metabolism. Int J Endocrinol. 2019; 2018:1968450. PMC: 6286734. DOI: 10.1155/2018/1968450. View

2.
Unfer V, Forte G . Does inositol ratio orchestrate the fate of ovarian follicles?. Med Hypotheses. 2020; 144:109983. DOI: 10.1016/j.mehy.2020.109983. View

3.
Zeng L, Yang K . Effectiveness of myoinositol for polycystic ovary syndrome: a systematic review and meta-analysis. Endocrine. 2017; 59(1):30-38. DOI: 10.1007/s12020-017-1442-y. View

4.
Heimark D, McAllister J, Larner J . Decreased myo-inositol to chiro-inositol (M/C) ratios and increased M/C epimerase activity in PCOS theca cells demonstrate increased insulin sensitivity compared to controls. Endocr J. 2013; 61(2):111-7. DOI: 10.1507/endocrj.ej13-0423. View

5.
Chukwuma C, Ibrahim M, Islam M . Myo-inositol inhibits intestinal glucose absorption and promotes muscle glucose uptake: a dual approach study. J Physiol Biochem. 2016; 72(4):791-801. DOI: 10.1007/s13105-016-0517-1. View